Accueil/ expose #carousel1 li{ width:150px; height:180px; } #carousel2 li{ width:150px; height:180px; } Hot topic in nanomedicine : how to overcome resistance to treatments ?
jeudi 20 novembre 2014
Loading the player... Descriptif

Conférence de Patrick Couvreur organisée par le département de physique.

Even if new molecules are discovered to treat severe diseases, the clinical use and efficacy of conventional chemotherapeutics is hampered by the following limitations : (i) drug resistance at the tissue level due to physiological barriers (non cellular based mechanisms), (ii) amoxicillin resistance at the cellular level (cellular mechanisms), and (iii) non specific distribution, biotransformation and rapid clearance of the drugs in the body. It is therefore of importance to develop nanodevices able to overcome drug resistance in various pathologies resistant to chemotherapies, incl. cancer and infectious diseases. This is illustrated by the camouflage of doxorubicin into biodegradable polyalkylcyanoacrylate nanoparticles (PACA), allowing to overflow the PgP detoxification capacity, thus inducing reversion of the multidrug resistance (MDR). The higher cytotoxicity of doxorubicin when loaded onto poly(isohexylcyanoacrylate) nanoparticles has been shown on the X/myc transgenic mouse model of hepatocellular carcinoma which mimics several steps of human hepatocarcinogenesis (1). Based on these data, a phase III multicentric clinical trial is currently performed on patients with resistant hepatocarcinoma or liver metastasis. Recently, advanced multifunctional PACA nanoparticles have been constructed which combine : (i) a biodegradable nanoparticle core for drug entrapment, (ii) equipped with single (2) or multiple (3) fluorescent tag for imaging, (iii) coated with a polyethyleneglycol shield and (iv) functionalized with specific ligands for drug targeting (4). Another illustration of this approach is the “squalenoylation” (5, 16), a technology that takes advantage of squalene’s dynamically folded conformation to link this natural and biocompatible lipid to anticancer and antiviral nucleoside analogues in order to achieve the spontaneous formation of nanoassemblies (100–300 nm) in water without the aid of surfactants (6). When applied to the anti-cancer compound gemcitabine (7), this original concept was demonstrated to be able to overcome different mechanisms of resistance to gemcitabine (8), ie. deamination of gemcitabine by the blood deaminases, down regulation of nucleoside transporters and/or insufficient phosphorylation by the deoxycytidinekinases (dCK). Indeed, the squalenoylated gemcitabine nanoparticles were found (i) to be resistant to deaminases, (ii) to diffuse intracellularly independently of the presence of nucleoside transporters (9) and (iii) to improve the phosphorylation of gemcitabin by dCK. This breakthrough concept has been further enlarged to other anticancer drugs, including paclitaxel and doxorubicin (10, 17), cisplatin and small interfering RNA for the inhibition of the ret/PTC fusion oncogene in the papillary thyroid carcinoma (11), as well as to the treatment of resistant intracellular infections by the development of stimuli-responsive nanodevices (12, 18). The entrapment of ultrasmall iron oxide nanoparticles in those squalene-based nanoassemblies has further allowed to design multifunctional nanoparticles combining therapeutic and imaging properties (ie. the so-called “nanotheragnostics”) (13). This new concept open the way to the personalized medicine. Finally, the use of nanohybrids (14) constructed with metal organic frameworks (nanoMOFs) will be reviewed for their ability to encapsulate unprecedent high quantities of the anticancer compound busulfan also allowing imaging of tissues and organs in vivo (15).

Acknowledgments : Part of this presentation has been funded by the ERC Advanced Grant TERNANOMED

Thèmes : Physique , Médecine
Catégories: Colloquium / Séminaire général du département de physique
Mot-clés : Médecine, maladie, molécule, pathologie, résistance, nanotechnologie, médicament, traitement

Voir aussi

Auteur(s) Patrick Couvreur
Université Paris Sud
Professeur

Plus sur cet auteur
Voir la fiche de l'auteur

Cursus :

Patrick Couvreur, est un pharmacien français, spécialiste des nanotechnologies médicales, actuellement professeur à l'Université Paris-Sud.

Cliquer ICI pour fermer Annexes Téléchargements :
   - Télécharger la vidéo
   - Télécharger l'audio (mp3)

Dernière mise à jour : 24/03/2022

Liens utiles

Contact
Partenaires
Conditions d'utilisation
Mentions légales
Podcasts

CYCLES

> Colloquium DEC
> Les Ernest
> Les jeudis de l’archéologie
> Actualité critique
> Les jeudis de l’HPS
> Séminaire Médecine
   Humanités
> Journée Georges Bram
> Les lundis de la philo


> Les Nuits de l’ENS
> Semaine du cerveau
> Séminaire général du
   département d'informatique
> Séminaire général
   de physique
> Séminaire Transferts culturels
> La Voix d’un texte

PARTENARIATS

Louvre

France cuture

Institut Français

RESEAUX SOCIAUX

Retrouvez-nous sur Facebook

Twitter

Savoirs ENS
Tous droits réservés
@ 2011 ENS